Share values in several biopharma’s have dropped after the Wall Street Journal reported that federal prosecutors have launched a criminal probe into whether biopharma companies purposely allowed painkillers to spread through US communities, fueling the opioid crisis. Teva slumped 8%, Amneal dropped 10%, and Mallinckrodt, McKesson, and AmeriSourceBergen all fell by more than 3% after the drugmakers and distributors received grand-jury subpoenas from the US attorney’s office in the Eastern District of New York, the Journal reported, citing regulatory filings. Other biopharma companies are likely to receive subpoenas in the coming months, the newspaper added. Learn More